- Home
- GBIO vs BFIN Comparison
GBIO vs BFIN Comparison
Compare GBIO & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- BFIN
- Stock Information
- Founded
- GBIO 2016
- BFIN 1924
- Country
- GBIO United States
- BFIN United States
- Employees
- GBIO N/A
- BFIN N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- BFIN Savings Institutions
- Sector
- GBIO Health Care
- BFIN Finance
- Exchange
- GBIO Nasdaq
- BFIN Nasdaq
- Market Cap
- GBIO 165.5M
- BFIN 156.3M
- IPO Year
- GBIO 2020
- BFIN N/A
- Fundamental
- Price
- GBIO $1.10
- BFIN $12.63
- Analyst Decision
- GBIO Strong Buy
- BFIN
- Analyst Count
- GBIO 2
- BFIN 0
- Target Price
- GBIO $7.50
- BFIN N/A
- AVG Volume (30 Days)
- GBIO 425.8K
- BFIN 15.9K
- Earning Date
- GBIO 11-06-2024
- BFIN 01-29-2025
- Dividend Yield
- GBIO N/A
- BFIN 3.18%
- EPS Growth
- GBIO N/A
- BFIN N/A
- EPS
- GBIO N/A
- BFIN 0.63
- Revenue
- GBIO $18,582,000.00
- BFIN $54,348,000.00
- Revenue This Year
- GBIO $212.74
- BFIN N/A
- Revenue Next Year
- GBIO N/A
- BFIN $0.85
- P/E Ratio
- GBIO N/A
- BFIN $19.93
- Revenue Growth
- GBIO 514.08
- BFIN N/A
- 52 Week Low
- GBIO $0.75
- BFIN $9.60
- 52 Week High
- GBIO $4.65
- BFIN $13.97
- Technical
- Relative Strength Index (RSI)
- GBIO 34.72
- BFIN 46.55
- Support Level
- GBIO $1.03
- BFIN $12.07
- Resistance Level
- GBIO $1.12
- BFIN $12.66
- Average True Range (ATR)
- GBIO 0.13
- BFIN 0.47
- MACD
- GBIO 0.02
- BFIN -0.09
- Stochastic Oscillator
- GBIO 55.56
- BFIN 28.96
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About BFIN BankFinancial Corporation
BankFinancial Corp is a national bank principally engaged in the business of commercial, family and personal banking. It offers customers a broad range of loan, deposit, trust and other financial products and services. The Bank offers customers a broad range of loan, deposit, trust and other financial products and services through all full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through Internet Branch.